Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | The importance of bridging the gap in awareness and diagnosis of amyloidosis around the world

Ramzi Tabbalat • 6 Sep 2022
ISA 2022
Amyloidosis Rare Diseases

Ramzi Tabbalat, MD, FACC, FSCCT, Abdali Medical Center, Amman, Jordan, discusses the importance of continuing to raise awareness of amyloidosis around the world, and further explains how the field has advanced in the last few years. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

More from Ramzi Tabbalat

3:51
Current diagnostic and management strategies for ATTR amyloidosis
Ramzi Tabbalat • 6 Sep 2022
2:12
Establishing regional centers of excellence to diagnose and treat amyloidosis: Jordan
Ramzi Tabbalat • 6 Sep 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals